Skip to content

Effectiveness of botulinum toxin A injection for shoulder internal rotaion contracture in children with obsteric brachial plexus palsy: a randomized controlled study

Effectiveness of botulinum toxin A injection for shoulder internal rotaion contracture in children with obsteric brachial plexus palsy: a randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024390
Enrollment
Unknown
Registered
2019-07-09
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obsteric brachial plexus palsy

Interventions

experimental group:botulinum toxin injection of teres major and subscapularis in addition to physical therapy
controlled group:physical therapy only

Sponsors

Renhe Hospital, Baoshan Branch of North Huashan Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. subjects diagnosed with obsteric brachial plexus palsy; 2. aged 2 to 6 years; 3. present with internal rotation contracture and limited active abduction of shoulder for at least 2 years after birth; 4. Modified Mallet Classification of shoulder abduction rated between 2-4; 5. decreased spinohumeral abduction angle during shoulder abduction; 6. body weight more than 10Kg; 7. EKG showed QTc<450ms; 8. compliance with physical therapy and keep up with the frequency, type and intensity required by the study protocol; 9. the legal guardian should know well about the aim of the study and is willing to obey and fulfill all the follow-ups of the study; 10. the legal guardian (usually the parents) has agreed with and signed the informed consent of this study.

Exclusion criteria

Exclusion criteria: 1. previous botulinum toxin injection or orthopedic surgery (e.g. muscle transfer or cutoff) on the affected arm, 2. previous trauma,fracture or nerve injury on either side of the arm; 3. concurrent central nervous system disease or injury; 4. infection or skin disease on the injection site; 5. in any situation which increase the risk of botulinum toxin injection,including myasthenia gravis, Eaton-Lambert syndrome,or other diseases interferring the nerve-muscle function; 6. concurrent use of aminoglycoside antibiotics or other medications interferring the nerve-muscle function; 7. concurrent severe cardiac,pulmonary, hepatic or renal diseases which may increase the risk,or affect the study result or disturb the study; 8. involved in other clincial study or has took part in other study in 30 days before enrollment of this study.

Design outcomes

Secondary

MeasureTime frame
difference of active ROM of shoulder abduction compared with baseline;proportion of effective treatment;difference of active ROM of shoulder external rotation compared with baseline;difference of spinohumeral abduction angle compared with baseline;difference of modified Mallet classificaiton compared with baseline;difference of muscle power of shoulder abduction and external rotation compared with baseline;general assessment by parents;surface EMG data of deltoid and teres major during active shoulder abduction;

Primary

MeasureTime frame
difference of active ROM of shoulder abduction compared with baseline;

Countries

China

Contacts

Public ContactHongqing Lu

Renhe Hospital, Baoshan Branch of North Huashan Hospital, Shanghai

1042412328@qq.com+86 18501646403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026